News
ORLANDO -- Palopegteriparatide (Yorvipath) led to sustained improvements over 2 years in adults with chronic ...
This paper is authored by Arpita Mukherjee, Aashish Chaudhry, Latika Khatwani, Trishali Khanna, Pallavi Verma – ICRIER, New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback